These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15217190)

  • 1. FR171456, a novel cholesterol synthesis inhibitor produced by Sporormiella minima No. 15604. II. Biological activities.
    Hatori H; Shibata T; Nishikawa M; Ueda H; Hino M; Fujii T
    J Antibiot (Tokyo); 2004 Apr; 57(4):260-3. PubMed ID: 15217190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FR171456, a novel cholesterol synthesis inhibitor produced by Sporormiella minima No. 15604. I. Taxonomy, fermentation, isolation, physico-chemical properties.
    Hatori H; Shibata T; Tsurumi Y; Nakanishi T; Katsuoka M; Ohtsu Y; Sakamoto K; Takase S; Ueda H; Hino M; Fujii T
    J Antibiot (Tokyo); 2004 Apr; 57(4):253-9. PubMed ID: 15217189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FR901512, a novel HMG-CoA reductase inhibitor produced by an agonomycetous fungus no. 14919. II. Biological profiles.
    Hatori H; Sato B; Sato I; Shibata T; Ueda H; Hino M; Fujii T
    J Antibiot (Tokyo); 2004 Jun; 57(6):390-3. PubMed ID: 15323128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor.
    Ioriya K; Kino K; Horisawa S; Nishimura T; Muraoka M; Noguchi T; Ohashi N
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of trapidil derivative AR 12456 on intracellular cholesterol homeostasis in human hepatoma cell line Hep G2.
    Corsini A; Grignaffini P; Beitz J; Mest HJ; Bellosta S; Fumagalli R; Paoletti R
    Cytotechnology; 1993; 11 Suppl 1():S15-7. PubMed ID: 7763747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of cholesterol biosynthesis increase hepatic low-density lipoprotein receptor protein degradation.
    Ness GC; Zhao Z; Lopez D
    Arch Biochem Biophys; 1996 Jan; 325(2):242-8. PubMed ID: 8561503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of a novel thyromimetic on lipoprotein metabolism.
    Taylor AH; Stephan ZF; Steele RE; Wong NC
    Mol Pharmacol; 1997 Sep; 52(3):542-7. PubMed ID: 9281617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
    Qin W; Infante J; Wang SR; Infante R
    Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New CETP inhibitor K-312 reduces PCSK9 expression: a potential effect on LDL cholesterol metabolism.
    Miyosawa K; Watanabe Y; Murakami K; Murakami T; Shibata H; Iwashita M; Yamazaki H; Yamazaki K; Ohgiya T; Shibuya K; Mizuno K; Tanabe S; Singh SA; Aikawa M
    Am J Physiol Endocrinol Metab; 2015 Jul; 309(2):E177-90. PubMed ID: 26015437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pravastatin on cholesterol metabolism of cholesterol-fed heterozygous WHHL rabbits.
    Harsch M; Gebhardt A; Reymann A; Lang G; Schliack M; Löser R; Braesen JH; Niendorf A
    Br J Pharmacol; 1998 May; 124(2):277-82. PubMed ID: 9641543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of PPARalpha lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2.
    König B; Koch A; Spielmann J; Hilgenfeld C; Stangl GI; Eder K
    Biochem Pharmacol; 2007 Feb; 73(4):574-85. PubMed ID: 17126302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters.
    Sugiyama Y; Ishikawa E; Odaka H; Miki N; Tawada H; Ikeda H
    Atherosclerosis; 1995 Feb; 113(1):71-8. PubMed ID: 7755657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogens induce low-density lipoprotein receptor activity and decrease intracellular cholesterol in human hepatoma cell line Hep G2.
    Semenkovich CF; Ostlund RE
    Biochemistry; 1987 Aug; 26(16):4987-92. PubMed ID: 2822102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A green tea catechin extract upregulates the hepatic low-density lipoprotein receptor in rats.
    Bursill CA; Roach PD
    Lipids; 2007 Jul; 42(7):621-7. PubMed ID: 17582541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phaleria macrocarpa (Scheff.) Boerl fruit aqueous extract enhances LDL receptor and PCSK9 expression in vivo and in vitro.
    Chong SC; Dollah MA; Chong PP; Maha A
    J Ethnopharmacol; 2011 Sep; 137(1):817-27. PubMed ID: 21763412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective compensatory induction of hepatic HMG-CoA reductase in response to inhibition of cholesterol absorption.
    Ness GC; Holland RC; Lopez D
    Exp Biol Med (Maywood); 2006 May; 231(5):559-65. PubMed ID: 16636304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profile of F 12511, (S)-2',3', 5'-trimethyl-4'-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor.
    Junquero D; Oms P; Carilla-Durand E; Autin J; Tarayre J; Degryse A; Patoiseau J; Colpaert FC; Delhon A
    Biochem Pharmacol; 2001 Jan; 61(1):97-108. PubMed ID: 11137714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
    Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FR171456 is a specific inhibitor of mammalian NSDHL and yeast Erg26p.
    Helliwell SB; Karkare S; Bergdoll M; Rahier A; Leighton-Davis JR; Fioretto C; Aust T; Filipuzzi I; Frederiksen M; Gounarides J; Hoepfner D; Hofmann A; Imbert PE; Jeker R; Knochenmuss R; Krastel P; Margerit A; Memmert K; Miault CV; Rao Movva N; Muller A; Naegeli HU; Oberer L; Prindle V; Riedl R; Schuierer S; Sexton JA; Tao J; Wagner T; Yin H; Zhang J; Roggo S; Reinker S; Parker CN
    Nat Commun; 2015 Oct; 6():8613. PubMed ID: 26456460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azalanstat (RS-21607), a lanosterol 14 alpha-demethylase inhibitor with cholesterol-lowering activity.
    Burton PM; Swinney DC; Heller R; Dunlap B; Chiou M; Malonzo E; Haller J; Walker KA; Salari A; Murakami S
    Biochem Pharmacol; 1995 Aug; 50(4):529-44. PubMed ID: 7646560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.